

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | aminoglycoside antibiotic metabolic process (GO:0030647) | 7.72968315 |
| 2 | somite rostral/caudal axis specification (GO:0032525) | 6.69928872 |
| 3 | maintenance of protein location in nucleus (GO:0051457) | 6.59916491 |
| 4 | negative regulation of epidermis development (GO:0045683) | 6.35286987 |
| 5 | regulation of response to osmotic stress (GO:0047484) | 6.19269904 |
| 6 | negative regulation of G2/M transition of mitotic cell cycle (GO:0010972) | 6.07868546 |
| 7 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 6.01947927 |
| 8 | protein localization to kinetochore (GO:0034501) | 5.66621464 |
| 9 | negative regulation of cell cycle G2/M phase transition (GO:1902750) | 5.52284744 |
| 10 | muscle organ morphogenesis (GO:0048644) | 5.50589047 |
| 11 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 5.41126604 |
| 12 | histone H4-K5 acetylation (GO:0043981) | 5.33796531 |
| 13 | histone H4-K8 acetylation (GO:0043982) | 5.33796531 |
| 14 | cytidine metabolic process (GO:0046087) | 5.32422047 |
| 15 | cytidine catabolic process (GO:0006216) | 5.32422047 |
| 16 | cytidine deamination (GO:0009972) | 5.32422047 |
| 17 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 5.25500262 |
| 18 | negative regulation of telomerase activity (GO:0051974) | 5.21167650 |
| 19 | rRNA transcription (GO:0009303) | 5.11602765 |
| 20 | histone H4-K12 acetylation (GO:0043983) | 5.09743924 |
| 21 | hormone catabolic process (GO:0042447) | 5.04319237 |
| 22 | regulation of MHC class I biosynthetic process (GO:0045343) | 5.00439486 |
| 23 | regulation of telomere maintenance via telomerase (GO:0032210) | 5.00274697 |
| 24 | interferon-gamma production (GO:0032609) | 4.97677453 |
| 25 | negative regulation of epidermal cell differentiation (GO:0045605) | 4.82181581 |
| 26 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 4.74316068 |
| 27 | heterochromatin organization (GO:0070828) | 4.69092114 |
| 28 | primitive streak formation (GO:0090009) | 4.64495949 |
| 29 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 4.64476535 |
| 30 | phenol-containing compound catabolic process (GO:0019336) | 4.41055003 |
| 31 | notochord development (GO:0030903) | 4.34127925 |
| 32 | mitotic sister chromatid segregation (GO:0000070) | 4.32190292 |
| 33 | positive regulation of protein deacetylation (GO:0090312) | 4.28011177 |
| 34 | nucleoside transmembrane transport (GO:1901642) | 4.22077456 |
| 35 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 4.20815730 |
| 36 | regulation of cilium movement (GO:0003352) | 4.18717829 |
| 37 | positive regulation of histone deacetylation (GO:0031065) | 4.13201231 |
| 38 | regulation of female receptivity (GO:0045924) | 4.11563815 |
| 39 | response to dietary excess (GO:0002021) | 4.09271455 |
| 40 | maintenance of protein localization in organelle (GO:0072595) | 4.07974159 |
| 41 | coenzyme catabolic process (GO:0009109) | 4.07533986 |
| 42 | positive regulation of DNA-dependent DNA replication (GO:2000105) | 4.05624499 |
| 43 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059) | 4.02429444 |
| 44 | histone H4-K16 acetylation (GO:0043984) | 4.00072506 |
| 45 | intestinal epithelial cell development (GO:0060576) | 3.98832256 |
| 46 | protein localization to chromosome, centromeric region (GO:0071459) | 3.98079804 |
| 47 | cellular modified amino acid catabolic process (GO:0042219) | 3.96878512 |
| 48 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.96775547 |
| 49 | chromatin assembly (GO:0031497) | 3.96329266 |
| 50 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.95614447 |
| 51 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.95614447 |
| 52 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.94618151 |
| 53 | regulation of translation in response to stress (GO:0043555) | 3.93681000 |
| 54 | maternal placenta development (GO:0001893) | 3.86438460 |
| 55 | vitamin A metabolic process (GO:0006776) | 3.85637737 |
| 56 | female mating behavior (GO:0060180) | 3.84360679 |
| 57 | retinoic acid receptor signaling pathway (GO:0048384) | 3.84244341 |
| 58 | rRNA methylation (GO:0031167) | 3.78102712 |
| 59 | quinone metabolic process (GO:1901661) | 3.77784153 |
| 60 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771) | 3.77081144 |
| 61 | mitochondrion distribution (GO:0048311) | 3.63228945 |
| 62 | tachykinin receptor signaling pathway (GO:0007217) | 3.61683017 |
| 63 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.61636062 |
| 64 | GDP-mannose metabolic process (GO:0019673) | 3.58328393 |
| 65 | trophectodermal cell differentiation (GO:0001829) | 3.57974434 |
| 66 | sister chromatid segregation (GO:0000819) | 3.55298059 |
| 67 | mRNA stabilization (GO:0048255) | 3.54076061 |
| 68 | RNA stabilization (GO:0043489) | 3.54076061 |
| 69 | cardiovascular system development (GO:0072358) | 3.50914532 |
| 70 | negative regulation of telomere maintenance (GO:0032205) | 3.50128271 |
| 71 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.47378561 |
| 72 | rRNA modification (GO:0000154) | 3.43752380 |
| 73 | cell fate commitment involved in formation of primary germ layer (GO:0060795) | 3.41395771 |
| 74 | hypotonic response (GO:0006971) | 3.41279708 |
| 75 | nuclear pore complex assembly (GO:0051292) | 3.37632283 |
| 76 | bone trabecula formation (GO:0060346) | 3.32888283 |
| 77 | regulation of intracellular estrogen receptor signaling pathway (GO:0033146) | 3.32306138 |
| 78 | epoxygenase P450 pathway (GO:0019373) | 3.32147501 |
| 79 | regulation of odontogenesis of dentin-containing tooth (GO:0042487) | 3.29395537 |
| 80 | pre-miRNA processing (GO:0031054) | 3.28888343 |
| 81 | arachidonic acid secretion (GO:0050482) | 3.26101796 |
| 82 | icosanoid secretion (GO:0032309) | 3.26101796 |
| 83 | regulation of cholesterol homeostasis (GO:2000188) | 3.25013147 |
| 84 | mannose metabolic process (GO:0006013) | 3.24766230 |
| 85 | glycosphingolipid catabolic process (GO:0046479) | 3.24301295 |
| 86 | barbed-end actin filament capping (GO:0051016) | 3.22279148 |
| 87 | response to muramyl dipeptide (GO:0032495) | 3.21560220 |
| 88 | negative regulation of cell size (GO:0045792) | 3.19806774 |
| 89 | transcription from mitochondrial promoter (GO:0006390) | 3.18244146 |
| 90 | proline transport (GO:0015824) | 3.18075409 |
| 91 | DNA replication checkpoint (GO:0000076) | 3.17663449 |
| 92 | regulation of hippo signaling (GO:0035330) | 3.17566908 |
| 93 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.17145581 |
| 94 | negative regulation of interleukin-2 production (GO:0032703) | 3.16712802 |
| 95 | regulation of extracellular matrix disassembly (GO:0010715) | 3.13411065 |
| 96 | positive regulation of odontogenesis (GO:0042482) | 3.13314745 |
| 97 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 3.12578914 |
| 98 | negative regulation of peptidyl-serine phosphorylation (GO:0033137) | 3.12278525 |
| 99 | signal transduction involved in regulation of gene expression (GO:0023019) | 3.11747771 |
| 100 | regulation of gene silencing by miRNA (GO:0060964) | 3.11664759 |
| 101 | regulation of gene silencing by RNA (GO:0060966) | 3.11664759 |
| 102 | regulation of posttranscriptional gene silencing (GO:0060147) | 3.11664759 |
| 103 | apoptotic DNA fragmentation (GO:0006309) | 3.08035269 |
| 104 | detection of bacterium (GO:0016045) | 3.07657419 |
| 105 | microtubule severing (GO:0051013) | 3.07193007 |
| 106 | negative regulation of granulocyte differentiation (GO:0030853) | 3.07040928 |
| 107 | establishment of endothelial barrier (GO:0061028) | 3.06752733 |
| 108 | regulation of telomerase activity (GO:0051972) | 3.05570077 |
| 109 | amyloid precursor protein catabolic process (GO:0042987) | 3.04967648 |
| 110 | nucleoside transport (GO:0015858) | 3.03068920 |
| 111 | intracellular estrogen receptor signaling pathway (GO:0030520) | 3.02584265 |
| 112 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.02550581 |
| 113 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.02072579 |
| 114 | adaptation of signaling pathway (GO:0023058) | 3.01456856 |
| 115 | glycolipid catabolic process (GO:0019377) | 2.99377964 |
| 116 | stress granule assembly (GO:0034063) | 2.98747224 |
| 117 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.94485557 |
| 118 | negative regulation of cell killing (GO:0031342) | 2.94485557 |
| 119 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.90694905 |
| 120 | negative regulation of T cell differentiation in thymus (GO:0033085) | 2.87043919 |
| 121 | detection of other organism (GO:0098543) | 2.86816460 |
| 122 | positive regulation of transcription from RNA polymerase III promoter (GO:0045945) | 2.86147683 |
| 123 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.85688898 |
| 124 | C21-steroid hormone biosynthetic process (GO:0006700) | 2.81793936 |
| 125 | signal complex assembly (GO:0007172) | 2.81407292 |
| 126 | tolerance induction (GO:0002507) | 2.80328773 |
| 127 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.76937731 |
| 128 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.75895458 |
| 129 | desmosome organization (GO:0002934) | 2.74587185 |
| 130 | semaphorin-plexin signaling pathway (GO:0071526) | 2.71023079 |
| 131 | proline metabolic process (GO:0006560) | 2.69717336 |
| 132 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.68171862 |
| 133 | ethanol metabolic process (GO:0006067) | 2.67699223 |
| 134 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.65799759 |
| 135 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.65416528 |
| 136 | Golgi transport vesicle coating (GO:0048200) | 2.63952023 |
| 137 | COPI coating of Golgi vesicle (GO:0048205) | 2.63952023 |
| 138 | maintenance of gastrointestinal epithelium (GO:0030277) | 2.62660554 |
| 139 | progesterone metabolic process (GO:0042448) | 2.61737427 |
| 140 | positive regulation of cholesterol efflux (GO:0010875) | 2.59445874 |
| 141 | response to peptidoglycan (GO:0032494) | 2.58653555 |
| 142 | regulation of gamma-delta T cell activation (GO:0046643) | 2.58446271 |
| 143 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.55003461 |
| 144 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.50648386 |
| 145 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.49520918 |
| 146 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.49520918 |
| 147 | phospholipid efflux (GO:0033700) | 2.49467055 |
| 148 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.48172150 |
| 149 | ceramide catabolic process (GO:0046514) | 2.45474013 |
| 150 | amyloid precursor protein metabolic process (GO:0042982) | 2.44712415 |
| 151 | regulation of cholesterol metabolic process (GO:0090181) | 2.44712189 |
| 152 | regulation of cholesterol storage (GO:0010885) | 2.38163236 |
| 153 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.36751952 |
| 154 | regulation of extracellular matrix organization (GO:1903053) | 2.36038660 |
| 155 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.35044700 |
| 156 | 4-hydroxyproline metabolic process (GO:0019471) | 2.34555176 |
| 157 | response to laminar fluid shear stress (GO:0034616) | 2.34342171 |
| 158 | urea cycle (GO:0000050) | 2.33973231 |
| 159 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.33327274 |
| 160 | response to thyroid hormone (GO:0097066) | 2.32221571 |
| 161 | urea metabolic process (GO:0019627) | 2.31031447 |
| 162 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.28911462 |
| 163 | regulation of leukocyte degranulation (GO:0043300) | 2.26829781 |
| 164 | germinal center formation (GO:0002467) | 2.26509236 |
| 165 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.26195067 |
| 166 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.24640620 |
| 167 | detection of external biotic stimulus (GO:0098581) | 2.24190853 |
| 168 | regulation of necrotic cell death (GO:0010939) | 2.24150982 |
| 169 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.23877489 |
| 170 | ethanol oxidation (GO:0006069) | 2.23585344 |
| 171 | complement activation, alternative pathway (GO:0006957) | 2.23349856 |
| 172 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 2.22986708 |
| 173 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.22658896 |
| 174 | N-acetylneuraminate metabolic process (GO:0006054) | 2.22062310 |
| 175 | oligosaccharide catabolic process (GO:0009313) | 2.21666744 |
| 176 | positive regulation of type 2 immune response (GO:0002830) | 2.21622156 |
| 177 | negative regulation of innate immune response (GO:0045824) | 2.21579439 |
| 178 | epithelial structure maintenance (GO:0010669) | 2.20819168 |
| 179 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.19644760 |
| 180 | nitrogen cycle metabolic process (GO:0071941) | 2.19348675 |
| 181 | alpha-linolenic acid metabolic process (GO:0036109) | 2.17940550 |
| 182 | positive regulation of cholesterol transport (GO:0032376) | 2.17638895 |
| 183 | positive regulation of sterol transport (GO:0032373) | 2.17638895 |
| 184 | NIK/NF-kappaB signaling (GO:0038061) | 2.17624148 |
| 185 | response to protozoan (GO:0001562) | 2.16761904 |
| 186 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.14804863 |
| 187 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.13588312 |
| 188 | sphingolipid catabolic process (GO:0030149) | 2.13577947 |
| 189 | regulation of bile acid biosynthetic process (GO:0070857) | 2.12083142 |
| 190 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.11861466 |
| 191 | modulation by symbiont of host immune response (GO:0052553) | 2.11861466 |
| 192 | positive regulation by symbiont of host defense response (GO:0052509) | 2.11861466 |
| 193 | modulation by symbiont of host defense response (GO:0052031) | 2.11861466 |
| 194 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.11861466 |
| 195 | daunorubicin metabolic process (GO:0044597) | 11.4118175 |
| 196 | polyketide metabolic process (GO:0030638) | 11.4118175 |
| 197 | doxorubicin metabolic process (GO:0044598) | 11.4118175 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.76472488 |
| 2 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 5.88152797 |
| 3 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 5.88152797 |
| 4 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 5.88152797 |
| 5 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.78116511 |
| 6 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 3.18844323 |
| 7 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.86251815 |
| 8 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 2.72472243 |
| 9 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 2.71941019 |
| 10 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 2.69672596 |
| 11 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 2.51931124 |
| 12 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 2.51084162 |
| 13 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 2.33132131 |
| 14 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.30232118 |
| 15 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.22046922 |
| 16 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.19621808 |
| 17 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 2.16012158 |
| 18 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 2.14575043 |
| 19 | MYC_22102868_ChIP-Seq_BL_Human | 2.03106549 |
| 20 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.03088182 |
| 21 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.98602188 |
| 22 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.95222503 |
| 23 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.94655758 |
| 24 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.87163162 |
| 25 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.87068857 |
| 26 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.85798654 |
| 27 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.82143229 |
| 28 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.80098327 |
| 29 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.79473998 |
| 30 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.78392312 |
| 31 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.77224531 |
| 32 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.74847641 |
| 33 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.74385318 |
| 34 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.71181355 |
| 35 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.70814213 |
| 36 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.69299660 |
| 37 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.68010046 |
| 38 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.66041711 |
| 39 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.64108848 |
| 40 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.63204339 |
| 41 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.63191298 |
| 42 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.62918776 |
| 43 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.60440380 |
| 44 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.56797687 |
| 45 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.54036938 |
| 46 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.53016448 |
| 47 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.52882418 |
| 48 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.51246086 |
| 49 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.50038659 |
| 50 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.48180207 |
| 51 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.47771686 |
| 52 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.47306147 |
| 53 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.45999491 |
| 54 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.44978067 |
| 55 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.44649686 |
| 56 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.43371055 |
| 57 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.42327300 |
| 58 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.41869525 |
| 59 | TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 1.41858098 |
| 60 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.41158475 |
| 61 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.40502727 |
| 62 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.40327002 |
| 63 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.39866413 |
| 64 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.38142800 |
| 65 | UTX_26944678_Chip-Seq_JUKART_Human | 1.37912969 |
| 66 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.36350795 |
| 67 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.35497538 |
| 68 | MAF_26560356_Chip-Seq_TH1_Human | 1.34145795 |
| 69 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.33730984 |
| 70 | MAF_26560356_Chip-Seq_TH2_Human | 1.33520917 |
| 71 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.33188841 |
| 72 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.32968046 |
| 73 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.32423090 |
| 74 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.28683499 |
| 75 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.28171186 |
| 76 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.28110038 |
| 77 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.27666110 |
| 78 | NANOG_18692474_ChIP-Seq_MESCs_Mouse | 1.26312135 |
| 79 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.26151250 |
| 80 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.24169810 |
| 81 | E2F1_17053090_ChIP-ChIP_MCF-7_Human | 1.23805061 |
| 82 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.23769287 |
| 83 | POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 1.23725707 |
| 84 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.23093447 |
| 85 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.22847880 |
| 86 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.22787433 |
| 87 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.22555881 |
| 88 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.22276923 |
| 89 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.22178392 |
| 90 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.22012236 |
| 91 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.21606394 |
| 92 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.21442940 |
| 93 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.21357607 |
| 94 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 1.20207643 |
| 95 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.19816747 |
| 96 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.19412483 |
| 97 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.18458607 |
| 98 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.18431234 |
| 99 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.18027077 |
| 100 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.17839141 |
| 101 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17785549 |
| 102 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.17373554 |
| 103 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.17137053 |
| 104 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.16581206 |
| 105 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.16517586 |
| 106 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.16363581 |
| 107 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.14754862 |
| 108 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.13724034 |
| 109 | SA1_27219007_Chip-Seq_Bcells_Human | 1.13475725 |
| 110 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11242156 |
| 111 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.10997368 |
| 112 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.10944458 |
| 113 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.10890853 |
| 114 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.10648895 |
| 115 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.09576627 |
| 116 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.08767098 |
| 117 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.08341375 |
| 118 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.07059382 |
| 119 | SOX2_18692474_ChIP-Seq_MESCs_Mouse | 1.06915974 |
| 120 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.06672711 |
| 121 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.05526893 |
| 122 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.05479946 |
| 123 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.05205916 |
| 124 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.05143910 |
| 125 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.04603606 |
| 126 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.04033808 |
| 127 | GATA1_19941826_ChIP-Seq_K562_Human | 1.02215380 |
| 128 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.02090428 |
| 129 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.01893859 |
| 130 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01711597 |
| 131 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.01343885 |
| 132 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.00670389 |
| 133 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.00319400 |
| 134 | KDM2B_26808549_Chip-Seq_K562_Human | 0.98977101 |
| 135 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.98700442 |
| 136 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.97262793 |
| 137 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.96684782 |
| 138 | NANOG_16518401_ChIP-PET_MESCs_Mouse | 0.95678027 |
| 139 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.95487418 |
| 140 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.92450952 |
| 141 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.91386542 |
| 142 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.90622283 |
| 143 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.90616187 |
| 144 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.90459634 |
| 145 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.90422561 |
| 146 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.90307539 |
| 147 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.88783858 |
| 148 | P68_20966046_ChIP-Seq_HELA_Human | 0.88119444 |
| 149 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.87785442 |
| 150 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.86237327 |
| 151 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.84273602 |
| 152 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.83491003 |
| 153 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.83465774 |
| 154 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.82458392 |
| 155 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.81634569 |
| 156 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.80886647 |
| 157 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.80485233 |
| 158 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.80293387 |
| 159 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.79858111 |
| 160 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.79472498 |
| 161 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.78897538 |
| 162 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.77045920 |
| 163 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.76744897 |
| 164 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.76710708 |
| 165 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.75938873 |
| 166 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.74349144 |
| 167 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.74140585 |
| 168 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.73480606 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004264_abnormal_extraembryonic_tissu | 4.90829008 |
| 2 | MP0002254_reproductive_system_inflammat | 4.65657276 |
| 3 | MP0003011_delayed_dark_adaptation | 4.54021815 |
| 4 | MP0005058_abnormal_lysosome_morphology | 3.95191982 |
| 5 | MP0004858_abnormal_nervous_system | 3.48800957 |
| 6 | MP0006292_abnormal_olfactory_placode | 3.40794672 |
| 7 | MP0003890_abnormal_embryonic-extraembry | 3.28114952 |
| 8 | MP0003436_decreased_susceptibility_to | 3.25347462 |
| 9 | MP0003705_abnormal_hypodermis_morpholog | 3.16732808 |
| 10 | MP0003724_increased_susceptibility_to | 3.10192705 |
| 11 | MP0005394_taste/olfaction_phenotype | 3.09147416 |
| 12 | MP0005499_abnormal_olfactory_system | 3.09147416 |
| 13 | MP0003191_abnormal_cellular_cholesterol | 2.92132702 |
| 14 | MP0009840_abnormal_foam_cell | 2.91848539 |
| 15 | MP0010352_gastrointestinal_tract_polyps | 2.83808806 |
| 16 | MP0005075_abnormal_melanosome_morpholog | 2.77034059 |
| 17 | MP0005360_urolithiasis | 2.76905098 |
| 18 | MP0003122_maternal_imprinting | 2.71527056 |
| 19 | MP0002332_abnormal_exercise_endurance | 2.70142913 |
| 20 | MP0008961_abnormal_basal_metabolism | 2.54927363 |
| 21 | MP0003183_abnormal_peptide_metabolism | 2.46359400 |
| 22 | MP0002139_abnormal_hepatobiliary_system | 2.35688826 |
| 23 | MP0008260_abnormal_autophagy | 2.35584935 |
| 24 | MP0005365_abnormal_bile_salt | 2.30106458 |
| 25 | MP0004957_abnormal_blastocyst_morpholog | 2.30086315 |
| 26 | MP0005257_abnormal_intraocular_pressure | 2.28887843 |
| 27 | MP0006035_abnormal_mitochondrial_morpho | 2.14298052 |
| 28 | MP0003300_gastrointestinal_ulcer | 2.12440975 |
| 29 | MP0008057_abnormal_DNA_replication | 2.11225541 |
| 30 | MP0002653_abnormal_ependyma_morphology | 2.11181639 |
| 31 | MP0000678_abnormal_parathyroid_gland | 2.08970032 |
| 32 | MP0006082_CNS_inflammation | 1.98360919 |
| 33 | MP0010155_abnormal_intestine_physiology | 1.93413247 |
| 34 | MP0005451_abnormal_body_composition | 1.92846157 |
| 35 | MP0009278_abnormal_bone_marrow | 1.91865959 |
| 36 | MP0001849_ear_inflammation | 1.90876161 |
| 37 | MP0003303_peritoneal_inflammation | 1.90512673 |
| 38 | MP0002127_abnormal_cardiovascular_syste | 1.86243938 |
| 39 | MP0008875_abnormal_xenobiotic_pharmacok | 1.84445042 |
| 40 | MP0004947_skin_inflammation | 1.82912756 |
| 41 | MP0001533_abnormal_skeleton_physiology | 1.80250712 |
| 42 | MP0003121_genomic_imprinting | 1.78577569 |
| 43 | MP0004043_abnormal_pH_regulation | 1.73289620 |
| 44 | MP0005025_abnormal_response_to | 1.70913900 |
| 45 | MP0001672_abnormal_embryogenesis/_devel | 1.68335823 |
| 46 | MP0005380_embryogenesis_phenotype | 1.68335823 |
| 47 | MP0000465_gastrointestinal_hemorrhage | 1.67349073 |
| 48 | MP0002088_abnormal_embryonic_growth/wei | 1.66316975 |
| 49 | MP0010030_abnormal_orbit_morphology | 1.64463408 |
| 50 | MP0003984_embryonic_growth_retardation | 1.64296815 |
| 51 | MP0002419_abnormal_innate_immunity | 1.59808848 |
| 52 | MP0003283_abnormal_digestive_organ | 1.51446366 |
| 53 | MP0009384_cardiac_valve_regurgitation | 1.51260437 |
| 54 | MP0005076_abnormal_cell_differentiation | 1.49330225 |
| 55 | MP0005000_abnormal_immune_tolerance | 1.41656459 |
| 56 | MP0002932_abnormal_joint_morphology | 1.39650758 |
| 57 | MP0001790_abnormal_immune_system | 1.39271922 |
| 58 | MP0005387_immune_system_phenotype | 1.39271922 |
| 59 | MP0003453_abnormal_keratinocyte_physiol | 1.38577919 |
| 60 | MP0003938_abnormal_ear_development | 1.33168244 |
| 61 | MP0000762_abnormal_tongue_morphology | 1.32320854 |
| 62 | MP0002277_abnormal_respiratory_mucosa | 1.26130181 |
| 63 | MP0009785_altered_susceptibility_to | 1.25094285 |
| 64 | MP0002933_joint_inflammation | 1.24864698 |
| 65 | MP0002086_abnormal_extraembryonic_tissu | 1.24181821 |
| 66 | MP0000350_abnormal_cell_proliferation | 1.22836171 |
| 67 | MP0001873_stomach_inflammation | 1.22087969 |
| 68 | MP0005266_abnormal_metabolism | 1.22052096 |
| 69 | MP0001800_abnormal_humoral_immune | 1.22029410 |
| 70 | MP0002092_abnormal_eye_morphology | 1.19871616 |
| 71 | MP0002452_abnormal_antigen_presenting | 1.19813724 |
| 72 | MP0000490_abnormal_crypts_of | 1.18778974 |
| 73 | MP0000749_muscle_degeneration | 1.18407822 |
| 74 | MP0001851_eye_inflammation | 1.18313989 |
| 75 | MP0009333_abnormal_splenocyte_physiolog | 1.18295312 |
| 76 | MP0002723_abnormal_immune_serum | 1.18171390 |
| 77 | MP0002148_abnormal_hypersensitivity_rea | 1.18136555 |
| 78 | MP0001293_anophthalmia | 1.17371080 |
| 79 | MP0002970_abnormal_white_adipose | 1.16864387 |
| 80 | MP0008004_abnormal_stomach_pH | 1.16318454 |
| 81 | MP0003763_abnormal_thymus_physiology | 1.15575579 |
| 82 | MP0001819_abnormal_immune_cell | 1.14371425 |
| 83 | MP0003123_paternal_imprinting | 1.13551129 |
| 84 | MP0003137_abnormal_impulse_conducting | 1.12592333 |
| 85 | MP0003828_pulmonary_edema | 1.12570623 |
| 86 | MP0000049_abnormal_middle_ear | 1.10649345 |
| 87 | MP0002420_abnormal_adaptive_immunity | 1.10491925 |
| 88 | MP0004185_abnormal_adipocyte_glucose | 1.09534434 |
| 89 | MP0002998_abnormal_bone_remodeling | 1.09527564 |
| 90 | MP0003329_amyloid_beta_deposits | 1.09092604 |
| 91 | MP0005390_skeleton_phenotype | 1.08773259 |
| 92 | MP0001845_abnormal_inflammatory_respons | 1.08329396 |
| 93 | MP0003075_altered_response_to | 1.07293065 |
| 94 | MP0000604_amyloidosis | 1.07039684 |
| 95 | MP0002085_abnormal_embryonic_tissue | 1.06509094 |
| 96 | MP0008789_abnormal_olfactory_epithelium | 1.06446482 |
| 97 | MP0001835_abnormal_antigen_presentation | 1.05933371 |
| 98 | MP0000750_abnormal_muscle_regeneration | 1.05214616 |
| 99 | MP0001545_abnormal_hematopoietic_system | 1.03966366 |
| 100 | MP0005397_hematopoietic_system_phenotyp | 1.03966366 |
| 101 | MP0005464_abnormal_platelet_physiology | 1.03422670 |
| 102 | MP0005248_abnormal_Harderian_gland | 1.03135692 |
| 103 | MP0003279_aneurysm | 1.03004104 |
| 104 | MP0003866_abnormal_defecation | 1.01654762 |
| 105 | MP0005670_abnormal_white_adipose | 1.01459137 |
| 106 | MP0008469_abnormal_protein_level | 1.01177569 |
| 107 | MP0003119_abnormal_digestive_system | 1.00974877 |
| 108 | MP0000003_abnormal_adipose_tissue | 1.00393610 |
| 109 | MP0005083_abnormal_biliary_tract | 1.00216337 |
| 110 | MP0002089_abnormal_postnatal_growth/wei | 1.00069641 |
| 111 | MP0004019_abnormal_vitamin_homeostasis | 0.99640184 |
| 112 | MP0010234_abnormal_vibrissa_follicle | 0.99537813 |
| 113 | MP0000428_abnormal_craniofacial_morphol | 0.98537684 |
| 114 | MP0001958_emphysema | 0.98520667 |
| 115 | MP0005666_abnormal_adipose_tissue | 0.98228529 |
| 116 | MP0002269_muscular_atrophy | 0.97890170 |
| 117 | MP0004510_myositis | 0.97116539 |
| 118 | MP0000681_abnormal_thyroid_gland | 0.97024463 |
| 119 | MP0002396_abnormal_hematopoietic_system | 0.95795782 |
| 120 | MP0008770_decreased_survivor_rate | 0.95755156 |
| 121 | MP0005085_abnormal_gallbladder_physiolo | 0.94928050 |
| 122 | MP0002084_abnormal_developmental_patter | 0.94686602 |
| 123 | MP0002114_abnormal_axial_skeleton | 0.94332149 |
| 124 | MP0002249_abnormal_larynx_morphology | 0.93494632 |
| 125 | MP0002233_abnormal_nose_morphology | 0.93121576 |
| 126 | MP0002118_abnormal_lipid_homeostasis | 0.92559540 |
| 127 | MP0002925_abnormal_cardiovascular_devel | 0.92457855 |
| 128 | MP0001348_abnormal_lacrimal_gland | 0.91775049 |
| 129 | MP0000609_abnormal_liver_physiology | 0.90942721 |
| 130 | MP0000685_abnormal_immune_system | 0.88565503 |
| 131 | MP0005375_adipose_tissue_phenotype | 0.88280601 |
| 132 | MP0005023_abnormal_wound_healing | 0.86997821 |
| 133 | MP0004084_abnormal_cardiac_muscle | 0.86593432 |
| 134 | MP0003077_abnormal_cell_cycle | 0.86207461 |
| 135 | MP0002877_abnormal_melanocyte_morpholog | 0.86124842 |
| 136 | MP0003935_abnormal_craniofacial_develop | 0.85884134 |
| 137 | MP0004197_abnormal_fetal_growth/weight/ | 0.85642394 |
| 138 | MP0009643_abnormal_urine_homeostasis | 0.84997759 |
| 139 | MP0002405_respiratory_system_inflammati | 0.84979239 |
| 140 | MP0002132_abnormal_respiratory_system | 0.84655619 |
| 141 | MP0000716_abnormal_immune_system | 0.83396879 |
| 142 | MP0005391_vision/eye_phenotype | 0.82714905 |
| 143 | MP0003690_abnormal_glial_cell | 0.82511064 |
| 144 | MP0008874_decreased_physiological_sensi | 0.81427949 |
| 145 | MP0000313_abnormal_cell_death | 0.79492611 |
| 146 | MP0001730_embryonic_growth_arrest | 0.79450604 |
| 147 | MP0000432_abnormal_head_morphology | 0.79346778 |
| 148 | MP0005166_decreased_susceptibility_to | 0.77787897 |
| 149 | MP0002909_abnormal_adrenal_gland | 0.77761710 |
| 150 | MP0005501_abnormal_skin_physiology | 0.77340017 |
| 151 | MP0005671_abnormal_response_to | 0.76162672 |
| 152 | MP0001216_abnormal_epidermal_layer | 0.76013569 |
| 153 | MP0002098_abnormal_vibrissa_morphology | 0.75503384 |
| 154 | MP0000477_abnormal_intestine_morphology | 0.75015232 |
| 155 | MP0003566_abnormal_cell_adhesion | 0.74545034 |
| 156 | MP0003879_abnormal_hair_cell | 0.74514146 |
| 157 | MP0005508_abnormal_skeleton_morphology | 0.74476842 |
| 158 | MP0002080_prenatal_lethality | 0.73972229 |
| 159 | MP0004782_abnormal_surfactant_physiolog | 0.73049825 |
| 160 | MP0000858_altered_metastatic_potential | 0.73017754 |
| 161 | MP0001697_abnormal_embryo_size | 0.72801657 |
| 162 | MP0010630_abnormal_cardiac_muscle | 0.71960523 |
| 163 | MP0000013_abnormal_adipose_tissue | 0.71851164 |
| 164 | MP0002971_abnormal_brown_adipose | 0.71093823 |
| 165 | MP0003172_abnormal_lysosome_physiology | 0.71055934 |
| 166 | MP0004381_abnormal_hair_follicle | 0.71002456 |
| 167 | MP0003448_altered_tumor_morphology | 0.69028766 |
| 168 | MP0004133_heterotaxia | 0.67954480 |
| 169 | MP0003755_abnormal_palate_morphology | 0.67727223 |
| 170 | MP0005330_cardiomyopathy | 0.67084339 |
| 171 | MP0003315_abnormal_perineum_morphology | 0.63969729 |
| 172 | MP0000377_abnormal_hair_follicle | 0.63333938 |
| 173 | MP0002116_abnormal_craniofacial_bone | 0.61920917 |
| 174 | MP0005253_abnormal_eye_physiology | 0.59317424 |
| 175 | MP0005319_abnormal_enzyme/_coenzyme | 0.58974864 |
| 176 | MP0002796_impaired_skin_barrier | 0.58358149 |
| 177 | MP0005310_abnormal_salivary_gland | 0.58349057 |
| 178 | MP0000759_abnormal_skeletal_muscle | 0.57341071 |
| 179 | MP0000266_abnormal_heart_morphology | 0.56707813 |
| 180 | MP0009703_decreased_birth_body | 0.56557652 |
| 181 | MP0006036_abnormal_mitochondrial_physio | 0.55284210 |
| 182 | MP0000358_abnormal_cell_content/ | 0.54654658 |
| 183 | MP0004087_abnormal_muscle_fiber | 0.53948465 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Bilateral microphthalmos (HP:0007633) | 7.31031387 |
| 2 | Hypochromic microcytic anemia (HP:0004840) | 5.97233654 |
| 3 | Multiple enchondromatosis (HP:0005701) | 5.82116383 |
| 4 | Hepatoblastoma (HP:0002884) | 5.62023511 |
| 5 | Abnormality of the lower motor neuron (HP:0002366) | 4.92738319 |
| 6 | Rib fusion (HP:0000902) | 4.55274983 |
| 7 | Ependymoma (HP:0002888) | 4.38275447 |
| 8 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.94910577 |
| 9 | Testicular atrophy (HP:0000029) | 3.94148570 |
| 10 | Systemic lupus erythematosus (HP:0002725) | 3.82315029 |
| 11 | Increased cerebral lipofuscin (HP:0011813) | 3.71259830 |
| 12 | Ragged-red muscle fibers (HP:0003200) | 3.71245789 |
| 13 | Dysostosis multiplex (HP:0000943) | 3.61286508 |
| 14 | Neoplasm of striated muscle (HP:0009728) | 3.53523452 |
| 15 | Eczematoid dermatitis (HP:0000976) | 3.35502759 |
| 16 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.35090644 |
| 17 | Loss of speech (HP:0002371) | 3.33961397 |
| 18 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 3.27800133 |
| 19 | Hypoplasia of the fovea (HP:0007750) | 3.27800133 |
| 20 | Abnormal cartilage morphology (HP:0002763) | 3.21455874 |
| 21 | Nephroblastoma (Wilms tumor) (HP:0002667) | 3.17216838 |
| 22 | Abnormality of the salivary glands (HP:0010286) | 3.17098007 |
| 23 | Fused cervical vertebrae (HP:0002949) | 3.16409509 |
| 24 | Rhabdomyosarcoma (HP:0002859) | 3.13792790 |
| 25 | Partial duplication of thumb phalanx (HP:0009944) | 3.09380546 |
| 26 | Flat acetabular roof (HP:0003180) | 3.06837089 |
| 27 | Astrocytoma (HP:0009592) | 3.02645243 |
| 28 | Abnormality of the astrocytes (HP:0100707) | 3.02645243 |
| 29 | Deep venous thrombosis (HP:0002625) | 2.96483896 |
| 30 | Embryonal renal neoplasm (HP:0011794) | 2.90422307 |
| 31 | Mucopolysacchariduria (HP:0008155) | 2.90343189 |
| 32 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.90343189 |
| 33 | Rectal fistula (HP:0100590) | 2.89386790 |
| 34 | Rectovaginal fistula (HP:0000143) | 2.89386790 |
| 35 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.83115911 |
| 36 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.83115911 |
| 37 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.83115911 |
| 38 | Complement deficiency (HP:0004431) | 2.82090031 |
| 39 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.81668662 |
| 40 | Preauricular pit (HP:0004467) | 2.79402855 |
| 41 | Periauricular skin pits (HP:0100277) | 2.79402855 |
| 42 | Stomach cancer (HP:0012126) | 2.76224113 |
| 43 | Intestinal fistula (HP:0100819) | 2.75096949 |
| 44 | Trismus (HP:0000211) | 2.74602217 |
| 45 | Amyotrophic lateral sclerosis (HP:0007354) | 2.74337939 |
| 46 | Horizontal nystagmus (HP:0000666) | 2.73916208 |
| 47 | Bifid tongue (HP:0010297) | 2.73361599 |
| 48 | Thin bony cortex (HP:0002753) | 2.72607064 |
| 49 | Anomalous pulmonary venous return (HP:0010772) | 2.70886829 |
| 50 | Increased connective tissue (HP:0009025) | 2.69056562 |
| 51 | Partial duplication of the phalanx of hand (HP:0009999) | 2.69050856 |
| 52 | Interstitial pulmonary disease (HP:0006530) | 2.68675006 |
| 53 | Pendular nystagmus (HP:0012043) | 2.67851018 |
| 54 | Hypochromic anemia (HP:0001931) | 2.67712926 |
| 55 | Short humerus (HP:0005792) | 2.67615330 |
| 56 | Aplasia/hypoplasia of the humerus (HP:0006507) | 2.64873063 |
| 57 | Abnormality of complement system (HP:0005339) | 2.63342912 |
| 58 | Vaginal fistula (HP:0004320) | 2.62869986 |
| 59 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.62846594 |
| 60 | Villous atrophy (HP:0011473) | 2.62846594 |
| 61 | Vacuolated lymphocytes (HP:0001922) | 2.62158532 |
| 62 | Polygenic inheritance (HP:0010982) | 2.61999570 |
| 63 | Abnormality of the fovea (HP:0000493) | 2.61499278 |
| 64 | Neoplasm of the heart (HP:0100544) | 2.61378911 |
| 65 | Glomerulonephritis (HP:0000099) | 2.59632186 |
| 66 | Hand muscle atrophy (HP:0009130) | 2.56784391 |
| 67 | Preauricular skin tag (HP:0000384) | 2.55967316 |
| 68 | Progressive muscle weakness (HP:0003323) | 2.55617136 |
| 69 | Generalized hypotonia (HP:0001290) | 2.51224031 |
| 70 | Myositis (HP:0100614) | 2.51123620 |
| 71 | Obstructive sleep apnea (HP:0002870) | 2.49617984 |
| 72 | Cervical subluxation (HP:0003308) | 2.47316262 |
| 73 | Abnormality of macrophages (HP:0004311) | 2.45851855 |
| 74 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.44823596 |
| 75 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.42493791 |
| 76 | Difficulty running (HP:0009046) | 2.41943951 |
| 77 | Nasal polyposis (HP:0100582) | 2.40512391 |
| 78 | Increased IgE level (HP:0003212) | 2.39169626 |
| 79 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.38293800 |
| 80 | Abnormal lung lobation (HP:0002101) | 2.37456666 |
| 81 | Neurofibrillary tangles (HP:0002185) | 2.37390444 |
| 82 | Reduced antithrombin III activity (HP:0001976) | 2.36715685 |
| 83 | Alveolar cell carcinoma (HP:0006519) | 2.36419477 |
| 84 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.35815254 |
| 85 | Short 5th finger (HP:0009237) | 2.35633035 |
| 86 | Skin tags (HP:0010609) | 2.35125315 |
| 87 | Shawl scrotum (HP:0000049) | 2.35121096 |
| 88 | Abnormality of the pubic bones (HP:0003172) | 2.33792017 |
| 89 | Recurrent abscess formation (HP:0002722) | 2.32948506 |
| 90 | Abnormality of the musculature of the hand (HP:0001421) | 2.30748511 |
| 91 | Renal duplication (HP:0000075) | 2.29004306 |
| 92 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.28695366 |
| 93 | Abnormality of the pulmonary veins (HP:0011718) | 2.28112751 |
| 94 | Colitis (HP:0002583) | 2.28062939 |
| 95 | Hemorrhage of the eye (HP:0011885) | 2.26356335 |
| 96 | Adenoma sebaceum (HP:0009720) | 2.26101676 |
| 97 | Angiofibromas (HP:0010615) | 2.26101676 |
| 98 | Microretrognathia (HP:0000308) | 2.25618207 |
| 99 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 2.23903950 |
| 100 | Skin pits (HP:0100276) | 2.23019735 |
| 101 | Broad face (HP:0000283) | 2.22553499 |
| 102 | Ventricular tachycardia (HP:0004756) | 2.22244226 |
| 103 | Flat capital femoral epiphysis (HP:0003370) | 2.22006627 |
| 104 | Nuclear cataract (HP:0100018) | 2.20724726 |
| 105 | Combined immunodeficiency (HP:0005387) | 2.20472763 |
| 106 | Glossoptosis (HP:0000162) | 2.20424163 |
| 107 | Cerebral aneurysm (HP:0004944) | 2.19880731 |
| 108 | Hydroxyprolinuria (HP:0003080) | 2.18957211 |
| 109 | Abnormality of proline metabolism (HP:0010907) | 2.18957211 |
| 110 | Tetraplegia (HP:0002445) | 2.17315353 |
| 111 | Large earlobe (HP:0009748) | 2.16894655 |
| 112 | Skin nodule (HP:0200036) | 2.16428821 |
| 113 | Cheilitis (HP:0100825) | 2.15282125 |
| 114 | Purpura (HP:0000979) | 2.14400808 |
| 115 | Joint stiffness (HP:0001387) | 2.13828841 |
| 116 | Gingivitis (HP:0000230) | 2.13656675 |
| 117 | Abnormality of the phalanges of the hallux (HP:0010057) | 2.13586927 |
| 118 | Spontaneous hematomas (HP:0007420) | 2.12647092 |
| 119 | Hyperventilation (HP:0002883) | 2.12442310 |
| 120 | Tongue fasciculations (HP:0001308) | 2.12385629 |
| 121 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.11848079 |
| 122 | Pseudobulbar signs (HP:0002200) | 2.11746948 |
| 123 | Aplasia/Hypoplasia of the macula (HP:0008059) | 2.11121127 |
| 124 | Abnormality of the intrinsic pathway (HP:0010989) | 2.10723131 |
| 125 | Malnutrition (HP:0004395) | 2.10530401 |
| 126 | Distal upper limb amyotrophy (HP:0007149) | 2.10386576 |
| 127 | Upper limb amyotrophy (HP:0009129) | 2.10386576 |
| 128 | Abnormality of the nasal mucosa (HP:0000433) | 2.10132358 |
| 129 | Aplasia/Hypoplasia of the 5th finger (HP:0006262) | 2.09208941 |
| 130 | Abnormality of chromosome segregation (HP:0002916) | 2.09117768 |
| 131 | Bone pain (HP:0002653) | 2.08879764 |
| 132 | Vertebral compression fractures (HP:0002953) | 2.08168452 |
| 133 | Sensory axonal neuropathy (HP:0003390) | 2.07745805 |
| 134 | Pustule (HP:0200039) | 2.07438429 |
| 135 | J-shaped sella turcica (HP:0002680) | 2.07234010 |
| 136 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.06229254 |
| 137 | Flattened epiphyses (HP:0003071) | 2.05253514 |
| 138 | Muscle fibrillation (HP:0010546) | 2.03990585 |
| 139 | Cellulitis (HP:0100658) | 2.02608958 |
| 140 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.01873808 |
| 141 | Seborrheic dermatitis (HP:0001051) | 2.01664425 |
| 142 | Malignant neoplasm of the central nervous system (HP:0100836) | 2.01226158 |
| 143 | Asymmetric septal hypertrophy (HP:0001670) | 2.00624254 |
| 144 | Resting tremor (HP:0002322) | 2.00341861 |
| 145 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.00078791 |
| 146 | Achilles tendon contracture (HP:0001771) | 1.99663983 |
| 147 | Abnormality of the thoracic spine (HP:0100711) | 1.99526216 |
| 148 | Thoracic kyphosis (HP:0002942) | 1.98808174 |
| 149 | Recurrent bacterial skin infections (HP:0005406) | 1.98170487 |
| 150 | Metaphyseal cupping (HP:0003021) | 1.97745867 |
| 151 | Neuronal loss in central nervous system (HP:0002529) | 1.97375142 |
| 152 | Obstructive lung disease (HP:0006536) | 1.97309550 |
| 153 | Chronic obstructive pulmonary disease (HP:0006510) | 1.97309550 |
| 154 | Vertebral fusion (HP:0002948) | 1.95961477 |
| 155 | Fasciculations (HP:0002380) | 1.95959239 |
| 156 | Abnormality of glycolipid metabolism (HP:0010969) | 1.95919040 |
| 157 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.95919040 |
| 158 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.95919040 |
| 159 | Right ventricular cardiomyopathy (HP:0011663) | 1.95348298 |
| 160 | Hyperacusis (HP:0010780) | 1.95145873 |
| 161 | Glioma (HP:0009733) | 1.95115551 |
| 162 | Atelectasis (HP:0100750) | 1.94926908 |
| 163 | Distal lower limb muscle weakness (HP:0009053) | 1.94203982 |
| 164 | Nasolacrimal duct obstruction (HP:0000579) | 1.93970984 |
| 165 | Hypopigmentation of the fundus (HP:0007894) | 1.93683283 |
| 166 | Hypertriglyceridemia (HP:0002155) | 1.93152838 |
| 167 | Distal lower limb amyotrophy (HP:0008944) | 1.92493369 |
| 168 | Mediastinal lymphadenopathy (HP:0100721) | 1.90548900 |
| 169 | Ankle clonus (HP:0011448) | 1.90382702 |
| 170 | Gastrointestinal inflammation (HP:0004386) | 1.86849876 |
| 171 | Nephritis (HP:0000123) | 1.86634645 |
| 172 | Axonal loss (HP:0003447) | 1.85270869 |
| 173 | Amyloidosis (HP:0011034) | 1.84684350 |
| 174 | Emphysema (HP:0002097) | 1.83904816 |
| 175 | * Abnormal enzyme/coenzyme activity (HP:0012379) | 1.83892972 |
| 176 | Aneurysm (HP:0002617) | 1.83628910 |
| 177 | Bronchomalacia (HP:0002780) | 1.83332805 |
| 178 | Hypophosphatemia (HP:0002148) | 1.82795105 |
| 179 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.82410042 |
| 180 | Stridor (HP:0010307) | 1.82000890 |
| 181 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.81611424 |
| 182 | Orchitis (HP:0100796) | 1.81451320 |
| 183 | Visceral angiomatosis (HP:0100761) | 1.78331394 |
| 184 | Hyperactive renin-angiotensin system (HP:0000841) | 1.76853107 |
| 185 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.76543462 |
| 186 | Abnormal tarsal ossification (HP:0008369) | 1.76307555 |
| 187 | Abdominal distention (HP:0003270) | 1.74800419 |
| 188 | Hypertensive crisis (HP:0100735) | 1.74740402 |
| 189 | Bulbar palsy (HP:0001283) | 1.74607465 |
| 190 | Abnormality of carpal bone ossification (HP:0006257) | 1.74284840 |
| 191 | Growth hormone excess (HP:0000845) | 1.74038137 |
| 192 | * Elevated alkaline phosphatase (HP:0003155) | 1.73964548 |
| 193 | Prolonged bleeding time (HP:0003010) | 1.72534972 |
| 194 | Epistaxis (HP:0000421) | 1.72382425 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDK12 | 8.15976495 |
| 2 | ERN1 | 5.36049398 |
| 3 | GRK5 | 5.09965079 |
| 4 | GRK6 | 4.54738620 |
| 5 | GRK1 | 3.02058874 |
| 6 | TGFBR2 | 2.78463825 |
| 7 | ADRBK2 | 2.70133533 |
| 8 | CSF1R | 2.56268428 |
| 9 | FGFR4 | 2.52365496 |
| 10 | TYRO3 | 2.50364195 |
| 11 | STK10 | 2.40595045 |
| 12 | MATK | 2.31930487 |
| 13 | MAP3K11 | 2.26932272 |
| 14 | GRK7 | 2.23624295 |
| 15 | MAPK7 | 2.18083609 |
| 16 | SMG1 | 2.04690638 |
| 17 | MAP3K10 | 2.01162552 |
| 18 | PRPF4B | 1.96506404 |
| 19 | TTK | 1.87256324 |
| 20 | MOS | 1.85704068 |
| 21 | WNK1 | 1.83435835 |
| 22 | MAP2K3 | 1.81412590 |
| 23 | TBK1 | 1.77564334 |
| 24 | MAP3K13 | 1.59512845 |
| 25 | MST1R | 1.52987860 |
| 26 | PRKG2 | 1.50982297 |
| 27 | MAP3K3 | 1.50473019 |
| 28 | CAMK4 | 1.47650901 |
| 29 | HIPK2 | 1.45978895 |
| 30 | PAK4 | 1.45307236 |
| 31 | TESK1 | 1.42774056 |
| 32 | RIPK4 | 1.40797141 |
| 33 | EPHB1 | 1.37730569 |
| 34 | NTRK1 | 1.37351730 |
| 35 | CDK7 | 1.31844410 |
| 36 | TNK2 | 1.31239155 |
| 37 | TYK2 | 1.28291256 |
| 38 | TRIB3 | 1.27686876 |
| 39 | MARK2 | 1.23951398 |
| 40 | FGFR3 | 1.23614632 |
| 41 | MAP3K14 | 1.21486694 |
| 42 | ZAP70 | 1.16781740 |
| 43 | CDC42BPA | 1.13977327 |
| 44 | EPHA2 | 1.09393963 |
| 45 | MAP2K2 | 1.07801729 |
| 46 | MAP3K1 | 1.06145363 |
| 47 | JAK3 | 1.04632191 |
| 48 | ADRBK1 | 1.00992580 |
| 49 | FGR | 0.97409054 |
| 50 | MAP3K6 | 0.94678013 |
| 51 | MAP3K7 | 0.92822527 |
| 52 | CSK | 0.90515173 |
| 53 | SIK3 | 0.90415690 |
| 54 | NME2 | 0.90102862 |
| 55 | FES | 0.89956554 |
| 56 | EPHA3 | 0.88774434 |
| 57 | MAP2K4 | 0.84703506 |
| 58 | TESK2 | 0.84568251 |
| 59 | ALK | 0.80174159 |
| 60 | BTK | 0.76959248 |
| 61 | MAP2K6 | 0.75771729 |
| 62 | IKBKE | 0.73020757 |
| 63 | RPS6KL1 | 0.72664334 |
| 64 | RPS6KC1 | 0.72664334 |
| 65 | CHEK2 | 0.72618896 |
| 66 | RPS6KA2 | 0.72575455 |
| 67 | BMX | 0.72020121 |
| 68 | MAPK15 | 0.71514018 |
| 69 | RIPK1 | 0.71314329 |
| 70 | SIK1 | 0.70406063 |
| 71 | ITK | 0.70042969 |
| 72 | BLK | 0.68908140 |
| 73 | MAPK12 | 0.67428668 |
| 74 | MTOR | 0.63928480 |
| 75 | CAMKK1 | 0.63298569 |
| 76 | LMTK2 | 0.62553501 |
| 77 | PDGFRA | 0.62173962 |
| 78 | AKT3 | 0.62070841 |
| 79 | AKT2 | 0.60158042 |
| 80 | PLK1 | 0.58440856 |
| 81 | JAK1 | 0.58184867 |
| 82 | PTK2 | 0.57690312 |
| 83 | RET | 0.56849486 |
| 84 | PKN2 | 0.56220264 |
| 85 | RPS6KA6 | 0.54661967 |
| 86 | TAOK3 | 0.51936798 |
| 87 | PDPK1 | 0.49205045 |
| 88 | PRKD2 | 0.49050290 |
| 89 | CHEK1 | 0.48751406 |
| 90 | TAOK1 | 0.48573927 |
| 91 | KDR | 0.47653613 |
| 92 | IRAK3 | 0.45224341 |
| 93 | CDK9 | 0.45177874 |
| 94 | LCK | 0.43452208 |
| 95 | PRKCI | 0.43300787 |
| 96 | ERBB2 | 0.42995026 |
| 97 | PRKD1 | 0.39904789 |
| 98 | LYN | 0.39055960 |
| 99 | MAPKAPK3 | 0.38943692 |
| 100 | ICK | 0.37609268 |
| 101 | IGF1R | 0.37074670 |
| 102 | EPHB2 | 0.37048351 |
| 103 | PIM2 | 0.36823196 |
| 104 | MET | 0.36657532 |
| 105 | DYRK1B | 0.36015227 |
| 106 | FYN | 0.35544562 |
| 107 | IRAK4 | 0.34615707 |
| 108 | MAP3K9 | 0.34289823 |
| 109 | RPS6KB2 | 0.32930293 |
| 110 | LATS2 | 0.31714641 |
| 111 | CDK4 | 0.31323513 |
| 112 | SIK2 | 0.30725039 |
| 113 | MAP4K1 | 0.30693334 |
| 114 | PRKCD | 0.29537314 |
| 115 | CDK2 | 0.28716753 |
| 116 | DDR2 | 0.28708584 |
| 117 | NEK2 | 0.27600689 |
| 118 | TTN | 0.25684014 |
| 119 | EEF2K | 0.23988770 |
| 120 | LRRK2 | 0.23949809 |
| 121 | INSR | 0.23502286 |
| 122 | PRKAA1 | 0.23048658 |
| 123 | NEK1 | 0.23034694 |
| 124 | GSK3A | 0.21374157 |
| 125 | STK38 | 0.21220669 |
| 126 | MAPKAPK2 | 0.20829494 |
| 127 | IKBKB | 0.19398268 |
| 128 | PRKACG | 0.19220253 |
| 129 | PAK1 | 0.19163689 |
| 130 | CHUK | 0.18846787 |
| 131 | MAPK1 | 0.17681890 |
| 132 | JAK2 | 0.17288179 |
| 133 | PRKCH | 0.17143164 |
| 134 | CSNK1E | 0.16986707 |
| 135 | MAPK10 | 0.16315103 |
| 136 | PAK3 | 0.15219289 |
| 137 | MAPK4 | 0.14236271 |
| 138 | AURKB | 0.13305043 |
| 139 | PTK6 | 0.13303656 |
| 140 | PDK1 | 0.12650555 |
| 141 | FLT3 | 0.12042484 |
| 142 | AURKA | 0.12011428 |
| 143 | TAOK2 | 0.11364751 |
| 144 | MAPK14 | 0.11352426 |
| 145 | HCK | 0.11309566 |
| 146 | ATM | 0.10843821 |
| 147 | PRKD3 | 0.10598759 |
| 148 | GSK3B | 0.10231509 |
| 149 | MAP3K8 | 0.09157928 |
| 150 | SRC | 0.09129170 |
| 151 | PRKACB | 0.08043553 |
| 152 | CDK1 | 0.07883660 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 6.73547031 |
| 2 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 4.89566751 |
| 3 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 4.33908786 |
| 4 | Galactose metabolism_Homo sapiens_hsa00052 | 3.20316528 |
| 5 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.76824278 |
| 6 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 2.50131212 |
| 7 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.41711056 |
| 8 | mTOR signaling pathway_Homo sapiens_hsa04150 | 2.14322996 |
| 9 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.04486837 |
| 10 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.99147761 |
| 11 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.93084595 |
| 12 | Thyroid cancer_Homo sapiens_hsa05216 | 1.85442987 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.82513944 |
| 14 | Lysosome_Homo sapiens_hsa04142 | 1.80509761 |
| 15 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.76684269 |
| 16 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.75157478 |
| 17 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.73007604 |
| 18 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.69995603 |
| 19 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.51795514 |
| 20 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.47177891 |
| 21 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.44421791 |
| 22 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.36963789 |
| 23 | Histidine metabolism_Homo sapiens_hsa00340 | 1.36204313 |
| 24 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.34526839 |
| 25 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.31051601 |
| 26 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.26146909 |
| 27 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.25519991 |
| 28 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.24028575 |
| 29 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.21286673 |
| 30 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.18815074 |
| 31 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.16713802 |
| 32 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.15432436 |
| 33 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.14055022 |
| 34 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.13720732 |
| 35 | Other glycan degradation_Homo sapiens_hsa00511 | 1.10550111 |
| 36 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.08307043 |
| 37 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.08295701 |
| 38 | Hepatitis C_Homo sapiens_hsa05160 | 1.07555193 |
| 39 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.07134033 |
| 40 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.04568994 |
| 41 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 1.04098690 |
| 42 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.00308895 |
| 43 | Pertussis_Homo sapiens_hsa05133 | 0.99220921 |
| 44 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.96949518 |
| 45 | Endometrial cancer_Homo sapiens_hsa05213 | 0.96711658 |
| 46 | ABC transporters_Homo sapiens_hsa02010 | 0.96339442 |
| 47 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.96207590 |
| 48 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.95888524 |
| 49 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.90060545 |
| 50 | Allograft rejection_Homo sapiens_hsa05330 | 0.88839706 |
| 51 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.88457556 |
| 52 | Bladder cancer_Homo sapiens_hsa05219 | 0.86434474 |
| 53 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.86250231 |
| 54 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.85472675 |
| 55 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.83625050 |
| 56 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.83158249 |
| 57 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.83006726 |
| 58 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.81633583 |
| 59 | Tuberculosis_Homo sapiens_hsa05152 | 0.81443909 |
| 60 | Prion diseases_Homo sapiens_hsa05020 | 0.81297519 |
| 61 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.80905221 |
| 62 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.80586623 |
| 63 | RNA transport_Homo sapiens_hsa03013 | 0.79987375 |
| 64 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.77759763 |
| 65 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.77744018 |
| 66 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.75781925 |
| 67 | Pathways in cancer_Homo sapiens_hsa05200 | 0.75281536 |
| 68 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.74763884 |
| 69 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.74757580 |
| 70 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.72914087 |
| 71 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.72512562 |
| 72 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.71786687 |
| 73 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.71694428 |
| 74 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.71620310 |
| 75 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.71553425 |
| 76 | Carbon metabolism_Homo sapiens_hsa01200 | 0.71552796 |
| 77 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.70929215 |
| 78 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.69796758 |
| 79 | Bile secretion_Homo sapiens_hsa04976 | 0.69539070 |
| 80 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.69048077 |
| 81 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.69026738 |
| 82 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.69001745 |
| 83 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.68914083 |
| 84 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.68738543 |
| 85 | Amoebiasis_Homo sapiens_hsa05146 | 0.68709912 |
| 86 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.68375828 |
| 87 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.67436287 |
| 88 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.67096288 |
| 89 | Apoptosis_Homo sapiens_hsa04210 | 0.66793863 |
| 90 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.66476624 |
| 91 | Insulin resistance_Homo sapiens_hsa04931 | 0.66327478 |
| 92 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.66043091 |
| 93 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.66040146 |
| 94 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.65712482 |
| 95 | Endocytosis_Homo sapiens_hsa04144 | 0.65224026 |
| 96 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.64969056 |
| 97 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.64311436 |
| 98 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.63755370 |
| 99 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.62831341 |
| 100 | Influenza A_Homo sapiens_hsa05164 | 0.62198315 |
| 101 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.61545595 |
| 102 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.60853760 |
| 103 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.59824801 |
| 104 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.58510968 |
| 105 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.58172978 |
| 106 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.58054602 |
| 107 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.57653921 |
| 108 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.56786127 |
| 109 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.56021309 |
| 110 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.55896082 |
| 111 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.55620961 |
| 112 | Lysine degradation_Homo sapiens_hsa00310 | 0.55389507 |
| 113 | Sulfur relay system_Homo sapiens_hsa04122 | 0.55379454 |
| 114 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.55331581 |
| 115 | Retinol metabolism_Homo sapiens_hsa00830 | 0.55058989 |
| 116 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.54541875 |
| 117 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.52517604 |
| 118 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.52306591 |
| 119 | Malaria_Homo sapiens_hsa05144 | 0.52243561 |
| 120 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.51632541 |
| 121 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.51242815 |
| 122 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.51084022 |
| 123 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.50950006 |
| 124 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.50107333 |
| 125 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.49621997 |
| 126 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.48919424 |
| 127 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.48631477 |
| 128 | Adherens junction_Homo sapiens_hsa04520 | 0.48240765 |
| 129 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.48159971 |
| 130 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.47956595 |
| 131 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.47678843 |
| 132 | Salmonella infection_Homo sapiens_hsa05132 | 0.47652589 |
| 133 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.47485760 |
| 134 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.47187688 |
| 135 | Shigellosis_Homo sapiens_hsa05131 | 0.47160972 |
| 136 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.47100599 |
| 137 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.45681505 |
| 138 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.45597892 |
| 139 | Cell cycle_Homo sapiens_hsa04110 | 0.44695900 |
| 140 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.44480127 |
| 141 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.43291742 |
| 142 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.42105459 |
| 143 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.41841813 |
| 144 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.39529315 |
| 145 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.39354869 |
| 146 | HTLV-I infection_Homo sapiens_hsa05166 | 0.37281700 |
| 147 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.37238813 |
| 148 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.33737281 |
| 149 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.33598670 |
| 150 | Leishmaniasis_Homo sapiens_hsa05140 | 0.33341987 |
| 151 | RNA degradation_Homo sapiens_hsa03018 | 0.33270315 |
| 152 | Tight junction_Homo sapiens_hsa04530 | 0.33246199 |
| 153 | Colorectal cancer_Homo sapiens_hsa05210 | 0.32463573 |
| 154 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.32244342 |
| 155 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.31553688 |
| 156 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.30161559 |
| 157 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.29881159 |
| 158 | Legionellosis_Homo sapiens_hsa05134 | 0.29091586 |
| 159 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.28861406 |
| 160 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.28856953 |

